Treatment Compliance Communications Between Patients with Severe Mental Illness and Treating Healthcare Providers: A Retrospective Study of Documentation Using Healthcare Reimbursement Claims and Medical Chart Abstraction

References

• Mokdad AH, Ballestros K, Echko M, et al. The state of US health, 1990–2016: burden of diseases, injuries, and risk factors among US states. JAMA. 2018;319:1444–1472. doi:10.1001/jama.2018.0158
   PubMed Web of Science ®Google Scholar
• Bloom DE, Cafiero ET, Jané-Llopis E, et al. The global economic burden of noncommunicable diseases. Geneva, Switzerland: World Economic Forum; 2011. Available from: https://www.weforum.org/reports/global-economic-burden-non-communicable-diseases. Accessed May 29, 2020.
   Google Scholar
• National Institute of Mental Health. Mental health information statistics; 2020. Bethesda, MD: NIH. Available from: https://www.nimh.nih.gov/health/statistics/mental-illness.shtml. Accessed May 29, 2020.
   Google Scholar
• Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76:155–162. doi:10.4088/JCP.14m09298
   PubMed Web of Science ®Google Scholar
• Cloutier M, Aigbogun MS, Guerin A, et al. The economic burden of schizophrenia in the United States in 2013. J Clin Psychiatry. 2016;77:764–771. doi:10.4088/JCP.15m10278
   PubMed Web of Science ®Google Scholar
• Cloutier M, Greene M, Guerin A, Touya M, Wu E. The economic burden of bipolar I disorder in the United States in 2015. J Affect Disord. 2018;226:45–51. doi:10.1016/j.jad.2017.09.011
   PubMed Web of Science ®Google Scholar
• Dixon LB, Holoshitz Y, Nossel I. Treatment engagement of individuals experiencing mental illness: review and update. World Psychiatry. 2016;15:13–20. doi:10.1002/wps.20306
   PubMed Web of Science ®Google Scholar
• Easter A, Pollock M, Pope LG, Wisdom JP, Smith TE. Perspectives of treatment providers and clients with serious mental illness regarding effective therapeutic relationships. J Behav Health Serv Res. 2016;43:341–353. doi:10.1007/s11414-015-9492-5
   PubMed Web of Science ®Google Scholar
• Thompson L, McCabe R. The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review. BMC Psychiatry. 2012;12:87. doi:10.1186/1471-244X-12-87
   PubMed Web of Science ®Google Scholar
• Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye G, Ankomah A. Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis. Syst Rev. 2020;9:17. doi:10.1186/s13643-020-1274-3
   PubMed Web of Science ®Google Scholar
• Desai R, Nayak R. Effects of medication nonadherence and comorbidity on health resource utilization in schizophrenia. J Manag Care Spec Pharm. 2019;25:37–44. doi:10.18553/jmcp.2019.25.1.037
   Web of Science ®Google Scholar
• Forma F, Green T, Kim S, Teigland C. Antipsychotic medication adherence and healthcare services utilization in two cohorts of patients with serious mental illness. Clinicoecon Outcomes Res. 2020;12:123–132. doi:10.2147/CEOR.S231000
   PubMed Web of Science ®Google Scholar
• Higashi K, Medic G, Littlewood KJ, Diez T, Granström O, De Hert M. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol. 2013;3:200–218. doi:10.1177/2045125312474019
   PubMedGoogle Scholar
• Jawad I, Watson S, Haddad PM, Talbot PS, McAllister-Williams RH. Medication nonadherence in bipolar disorder: a narrative review. Ther Adv Psychopharmacol. 2018;8:349–363. doi:10.1177/2045125318804364
   PubMed Web of Science ®Google Scholar
• Jiang Y, Ni W. Estimating the impact of adherence to and persistence with atypical antipsychotic therapy on health care costs and risk of hospitalization. Pharmacotherapy. 2015;35:813–822. doi:10.1002/phar.1634
   PubMed Web of Science ®Google Scholar
• Hong J, Reed C, Novick D, Haro JM, Aguado J. Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study. Psychiatry Res. 2011;190:110–114. doi:10.1016/j.psychres.2011.04.016
   PubMed Web of Science ®Google Scholar
• Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res. 2010;176:109–113. doi:10.1016/j.psychres.2009.05.004
   PubMed Web of Science ®Google Scholar
• Offord S, Lin J, Mirski D, Wong B. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia. Adv Ther. 2013;30:286–297. doi:10.1007/s12325-013-0016-5
   PubMed Web of Science ®Google Scholar
• De Las Cuevas C, de Leon J, Peñate W, Betancort M. Factors influencing adherence to psychopharmacological medications in psychiatric patients: a structural equation modeling approach. Patient Prefer Adher. 2017;11:681–690. doi:10.2147/PPA.S133513
   PubMed Web of Science ®Google Scholar
• Chapman SC, Horne R. Medication nonadherence and psychiatry. Curr Opin Psychiatry. 2013;26:446–452. doi:10.1097/YCO.0b013e3283642da4
   PubMed Web of Science ®Google Scholar
• Velligan DI, Sajatovic M, Hatch A, Kramata P, Docherty JP. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Prefer Adher. 2017;11:449–468. doi:10.2147/PPA.S124658
   PubMed Web of Science ®Google Scholar
• Mago R. Adverse effects of psychotropic medications: a call to action. Psychiatr Clin North Am. 2016;39:361–373. doi:10.1016/j.psc.2016.04.005
   PubMed Web of Science ®Google Scholar
• Velligan DI, Fredrick MM, Sierra C, et al. Engagement-focused care during transitions from inpatient and emergency psychiatric facilities. Patient Prefer Adher. 2017;11:919–928. doi:10.2147/PPA.S132339
   Web of Science ®Google Scholar
• Lakdawala PD. Doctor-patient relationship in psychiatry. Mens Sana Monogr. 2015;13:82–90. doi:10.4103/0973-1229.153308
   PubMedGoogle Scholar
• Chakrabarti S. Treatment alliance and adherence in bipolar disorder. World J Psychiatry. 2018;8:114–124. doi:10.5498/wjp.v8.i5.114
   PubMed Web of Science ®Google Scholar
• Tessier A, Boyer L, Husky M, Bayle F, Llorca PM, Misdrahi D. Medication adherence in schizophrenia: the role of insight, therapeutic alliance, and perceived trauma associated with psychiatric care. Psychiatry Res. 2017;257:315–321. doi:10.1016/j.psychres.2017.07.063
   PubMed Web of Science ®Google Scholar
• Kreyenbuhl J, Record EJ, Palmer-Bacon J. A review of behavioral tailoring strategies for improving medication adherence in serious mental illness. Dialogues Clin Neurosci. 2016;18:191–201. doi:10.31887/DCNS.2016.18.2/jkreyenbuhl
   PubMed Web of Science ®Google Scholar
• Velligan DI, Weiden PJ, Sajatovic M, et al.; Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70(Suppl 4):1–46. doi:10.4088/JCP.7090su1cj
   PubMed Web of Science ®Google Scholar
• Census regions and divisions of the United States; 2020. Available from: https://www2.census.gov/programs-surveys/sahie/reference-maps/2017/us-regdiv.pdf. Accessed May 29, 2020.
   Google Scholar
• Clinical Classifications Software (CCS). Clinical Classifications Software (CCS) for ICD-9-CM/ICD-10/CM; 2020. Rockville, MD: Agency for Healthcare Research and Quality. Available from: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed May 29, 2020.
   Google Scholar
• Quan H, Li B, Couris CM, et al. Updating and validating the Charlson Comorbidity Index and Score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–682. doi:10.1093/aje/kwq433
   PubMed Web of Science ®Google Scholar
• US Department of Labor, Bureau of Labor Statistics. Consumer price index. Medical care. Series ID: SUUR0000SAM; 2017. Available from: http://data.bls.gov/cgi-bin/surveymost?su.2018. Accessed May 29, 2020.
   Google Scholar
• APA Guideline Writing Group. American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. Copyright 2019, APA; 2020. Washington, DC: APA. Available from: https://www.psychiatry.org/psychiatrists/practice/clinical-practice-guidelines/review-draft-guidelines. Accessed May 29, 2020.
   Google Scholar
• Takeuchi H, Siu C, Remington G, et al. Does relapse contribute to treatment resistance? Antipsychotic response in first-vs. second-episode schizophrenia. Neuropsychopharmacol. 2019;44:1036–1042. doi:10.1038/s41386-018-0278-3
   PubMed Web of Science ®Google Scholar
• Bozzatello P, Bellino S, Rocca P. Predictive factors of treatment resistance in first episode of psychosis: a systematic review. Front Psychiatry. 2019;10:67. doi:10.3389/fpsyt.2019.00067
   PubMed Web of Science ®Google Scholar
• National Committee for Quality Assurance. Draft document for HEDIS Public Comment: HEDIS health plan follow-up after hospitalization for mental illness (FUH) measure; 2020. Washington, DC: NCQA. Available from: https://www.ncqa.org/hedis/measures/follow-up-after-hospitalization-for-mental-illness/. Accessed May 29, 2020.
   Google Scholar
• Beadles C, Ellis AR, Lichstein JC, et al. First outpatient follow-up after psychiatric hospitalization: does one size fit all? Psychiatric Serv. 2015;66:364–372. doi:10.1176/appi.ps.201400081
   PubMed Web of Science ®Google Scholar